Isolation and characterization of 23-O-mycinosyl-20-dihydro-rosamicin: A new rosamicin analogue derived from engineered Micromonospora rosaria

Journal of Antibiotics

Volumn 63, Issue 6, 2010, Pages 325-328

  Anzai, Yojiro ^a   Sakai, Ayami ^a   Li, Wei ^a   Iizaka, Yohei ^a   Koike, Kazuo ^a   Kinoshita, Kenji ^b   Kato, Fumio ^a  

^a TOHO UNIVERSITY   (Japan)

^b MUKOGAWA WOMEN'S UNIVERSITY   (Japan)

Author keywords

genetic engineering; mycinose; rosamicin

Indexed keywords

23 O MYCINOSYL 20 DIHYDROROSAMICIN; ROSARAMICIN DERIVATIVE; UNCLASSIFIED DRUG; 23 O MYCINOSYL 20 DIHYDRO ROSAMICIN; 23-O-MYCINOSYL-20-DIHYDRO-ROSAMICIN; ANTIINFECTIVE AGENT; DRUG DERIVATIVE; KITASAMYCIN; KITASAMYCIN DERIVATIVE; ROSARAMICIN;

ANTIBACTERIAL ACTIVITY; ARTICLE; BIOENGINEERING; CARBON NUCLEAR MAGNETIC RESONANCE; DRUG ISOLATION; ESCHERICHIA COLI; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MICROCOCCUS LUTEUS; MICROMONOSPORA; MICROMONOSPORA ROSARIA; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SALMONELLA TYPHIMURIUM; STAPHYLOCOCCUS AUREUS; BACTERIUM; DRUG EFFECT; GENETIC ENGINEERING; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGICAL EXAMINATION; NUCLEAR MAGNETIC RESONANCE;

MICROMONOSPORA ROSARIA;

ANTI-BACTERIAL AGENTS; BACTERIA; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GENETIC ENGINEERING; KITASAMYCIN; LEUCOMYCINS; MICROBIAL SENSITIVITY TESTS; MICROMONOSPORA; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR;

EID: 77954171976     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.1038/ja.2010.38     Document Type: Article

References (14)

1. Rodriguez, E. & McDaniel, R. Combinatorial biosynthesis of antimicrobials and other natural products. Curr. Opin. Microbiol. 4, 526-534 (2001).
2. Salas, J. A. & Mendez, C. Engineering the glycosylation of natural products in actinomycetes. Trends Microbiol. 15, 219-232 (2007).
3. Wagman, G. H. et al. New Micromonospora-produced macrolide antibiotic, rosamicin. J. Antibiot. 25, 641-652 (1972).
4. Anzai, Y. et al. Production of rosamicin derivatives in Micromonospora rosaria by introduction of D-mycinose biosynthetic gene with fC31-derived integration vector pSET152. J. Ind. Microbiol. Biotechnol. 36, 1013-1021 (2009).
5. Anzai,Y.et al. Organization of the biosynthetic gene cluster for the polyketide macrolide mycinamicin in Micromonospora griseorubida. FEMS Microbiol. Lett. 218, 135-141 (2003).
6. Anzai, Y. et al. Functional analysis of MycCI and MycG, cytochrome P450 enzymes involved in biosynthesis of mycinamicin macrolide antibiotics. Chem. Biol. 15, 950-959 (2008).
7. Li, S., Anzai, Y., Kinoshita, K., Kato, F. & Sherman, D. H. Functional analysis of MycE and MycF, two O-methyltransferases involved in biosynthesis of mycinamicin macrolide antibiotics. Chem. Biol. Chem. 10, 1297-1301 (2009).
8. Nakajima, S., Kojiri, K., Morishima, H. & Okanishi, M. New analogs of rosaramicin isolated from a Micromonospora strain. II. Structure determination. J. Antibiot. 43, 1006-1009 (1990).
9. O'mura, S. et al. Carbon-13 nuclear magnetic resonance spectral analysis of 16-membered macrolide antibiotics. J. Am. Chem. Soc. 97, 4001-4009 (1975).
10. Simova, S. & Ivanova, G. Proton and carbon chemical shift assignment and solutionstate conformation of macrocyclic ring in macrolide antibiotic tylosin in aprotic solvents. Magn. Reson. Chem. 34, 255-260 (1966).
11. Lee, B. K. et al. Multistep bioconversion of 20-deoxo-20-dihydro-12,13- deepoxy-12,13-dehydrorosaranolide to 22-hydroxy-23-O-mycinosyl-20-deoxo-20- dihydro-12,13-deepoxyrosaramicin. J. Antibiot. 36, 742-744 (1983).
12. Baltz, R. H. & Seno, E. T. Properties of Streptomyces fradiae mutants blocked in biosynthesis of the macrolide antibiotic tylosin. Antimicrob. Agents Chemother. 20, 214-225 (1981).
13. Baltz, R. H., Seno, E. T., Stonesifer, J. & Wild, G. M. Biosynthesis of the macrolide antibiotic tylosin a preferred pathway from tylactone to tylosin. J. Antibiot. 36, 131-141 (1972).
14. Merson-Davies, L. A. & Cundliffe, E. Analysis of five tylosin biosynthetic genes from the tylIBA region of the Streptomyces fradiae genome. Mol. Microbiol. 13, 349-355 (1994).